Recorded Q3'24 consolidated revenue of KRW 1.2 trillion Recorded Q3'24 consolidated operating profit of KRW 338.6 billion Continued business expansion through strong competitive edge in speed and execution INCHEON, South Korea, Oct. 23, 2024 /PRNewswire/ -- Samsung Biologics (KRX:...
Samsung Biologics reports third quarter 2024 financial results
Seaking AlphaSeeking Alpha / Seaking Alpha 5 hours ago 1 Views
Comments